In vivo efficacies of combinations of beta-lactams, beta-lactamase inhibitors, and rifampin against Acinetobacter baumannii in a mouse pneumonia model.
Wolff M, Joly-Guillou ML, Farinotti R, Carbon C.
Wolff M, et al.
Antimicrob Agents Chemother. 1999 Jun;43(6):1406-11. doi: 10.1128/AAC.43.6.1406.
Antimicrob Agents Chemother. 1999.
PMID: 10348761
Free PMC article.
The effects of various regimens containing combinations of beta-lactams, beta-lactam inhibitor(s), and rifampin were assessed in a recently described mouse model of Acinetobacter baumannii pneumonia (M. L. Joly-Guillou, M. Wolff, J. J. Pocidalo, F. Walker, an …
The effects of various regimens containing combinations of beta-lactams, beta-lactam inhibitor(s), and rifampin were assessed in a recently …